User profiles for "author:M Hawkins"

Melanie Hawkins

Swinburne University of Technology
Verified email at swin.edu.au
Cited by 3076

[PDF][PDF] High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

…, M Sznol, D Parkinson, M Hawkins… - Journal of clinical …, 1999 - llusurgonc.org
Purpose: To determine the short-and long-term efficacy and toxicity of the high-dose
intravenous bolus interleukin 2 (IL-2) regimen in patients with metastatic melanoma. Patients …

Protein nanoparticles as drug carriers in clinical medicine

MJ Hawkins, P Soon-Shiong, N Desai - Advanced drug delivery reviews, 2008 - Elsevier
Solvent-based delivery vehicles for chemotherapy agents have been instrumental in
providing a means for hydrophobic agents to be administered intravenously. These solvents …

β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment

PA Halban, KS Polonsky, DW Bowden… - The Journal of …, 2014 - academic.oup.com
OBJECTIVE: This article examines the foundation of β-cell failure in type 2 diabetes (T2D)
and suggests areas for future research on the underlying mechanisms that may lead to …

[HTML][HTML] Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

UB Pajvani, M Hawkins, TP Combs, MW Rajala… - Journal of Biological …, 2004 - ASBMB
Adiponectin is an adipocyte-specific secretory protein that circulates in serum as a hexamer
of relatively low molecular weight (LMW) and a larger multimeric structure of high molecular …

[PS][PS] Electrochemically induced nuclear fusion of deuterium

M Fleischmann, S Pons, M Hawkins - 1989 - metalab.unc.edu
Introduction The strange behaviour of electrogenerated hydrogen disolved in palladium has
been studied for well over 100 years and lately these studies have been extended to …

Risk of venous thromboembolism in users of hormone replacement therapy

E Daly, MP Vessey, MM Hawkins, JL Carson, P Gough… - The Lancet, 1996 - thelancet.com
Background The association between current use of oral contraceptives and increased risk
of venous thromboembolism (VTE) has been firmly established. Although data-sheets for …

Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancer

…, H Shaw, N Desai, P Bhar, M Hawkins… - Journal of clinical …, 2005 - ascopubs.org
Purpose ABI-007, the first biologically interactive albumin-bound paclitaxel in a nanameter
particle, free of solvents, was compared with polyethylated castor oil–based standard …

The gene encoding phosphodiesterase 4D confers risk of ischemic stroke

…, OB Einarsson, HM Gudjonsdottir, M Hawkins… - Nature …, 2003 - nature.com
We previously mapped susceptibility to stroke to chromosome 5q12. Here we finely mapped
this locus and tested it for association with stroke. We found the strongest association in the …

Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with …

…, D Dykes, P Noker, R Yao, E Labao, M Hawkins… - Clinical cancer research …, 2006 - AACR
Abstract ABI-007, an albumin-bound, 130-nm particle form of paclitaxel, was developed to
avoid Cremophor/ethanol-associated toxicities in Cremophor-based paclitaxel (Taxol) and …

[HTML][HTML] Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer

MR Green, GM Manikhas, S Orlov, B Afanasyev… - Annals of oncology, 2006 - Elsevier
Abstract Background: Abraxane®(ABI-007) is a novel 130-nm, albumin-bound (nab™)
particle form of paclitaxel designed to utilize endogenous albumin pathways to increase …